Eileen Martin to Anti-HIV Agents
This is a "connection" page, showing publications Eileen Martin has written about Anti-HIV Agents.
Connection Strength
1.055
-
An investigation of the effects of antiretroviral central nervous system penetration effectiveness on procedural learning in HIV+ drug users. J Clin Exp Neuropsychol. 2013; 35(9):915-25.
Score: 0.416
-
Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report. J Clin Exp Neuropsychol. 1999 Oct; 21(5):730-5.
Score: 0.157
-
Neuropsychological changes in efavirenz switch regimens. AIDS. 2019 07 01; 33(8):1307-1314.
Score: 0.155
-
Information processing and antiretroviral therapy in HIV-1 infection. J Int Neuropsychol Soc. 1998 Jul; 4(4):329-35.
Score: 0.144
-
Neuropsychological functioning in a cohort of HIV infected women: importance of antiretroviral therapy. J Int Neuropsychol Soc. 2002 Sep; 8(6):781-93.
Score: 0.048
-
Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study. AIDS. 2018 07 31; 32(12):1679-1688.
Score: 0.036
-
Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus. J Neurovirol. 2017 08; 23(4):558-567.
Score: 0.033
-
Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men. Antivir Ther. 2015; 20(2):235-44.
Score: 0.029
-
Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neurovirol. 2010 Oct; 16(5):335-41.
Score: 0.021
-
Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women. AIDS. 2005 Oct 14; 19(15):1659-67.
Score: 0.015